Phenotypic Characterization Harlan Howard, PhD. Describes the animal, construct, and proposed claim Are there sequences that are likely to contain potential.

Slides:



Advertisements
Similar presentations
Unit 1 - Introduction “bios” – life, living things, “logy” – the study of Biology - the study of life Major branches of biology: Zoology – the study of.
Advertisements

Office of New Animal Drug Evaluation Laura L. Hungerford, DVM, MPH, PhD Senior Advisor, Science and Policy, ONADE Professor, University of Maryland School.
 This training module applies to all farm animals derived through deliberate human technological intervention, including: dairy and beef cattle dairy.
Effectiveness Evaluation for Production Drugs Crystal Groesbeck, Ph.D Division of Production Drugs.
Comparator Selection in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
CODE OF PRACTICE AND COMMODITIES STANDARDS, PRESENTED AT NIGERIA AFLATOXIN WORKSHOP BY STANDARDS ORGANISATION OF NIGERIA.
Regulatory Toxicology James Swenberg, D.V.M., Ph.D.
Are They Safe? Biotech Food Crops and Products February 1, 2002 Karen Pesaresi Penner Kansas State University Food Science Institute.
1 MANUFACTURING AND PRODUCTION OF BIOLOGICAL PRODUCTS (ERT 455) HAZARD ANALYSIS AND CRITICAL CONTROL POINT (HACCP) SYSTEM Munira Mohamed Nazari School.
Current Perspectives on Biotechnology: Projects and Future Challenges/Opportunities Jordan BeanDr. Jaimie Schnell Novel Foods SectionPlant Health and Biotechnology.
Molecular Biology. It’s a Matter of Perspective The investigators who submit IBC protocols want to perform their experiments safely. The investigators.
What Do Toxicologists Do?
Safety and Regulation in Agricultural Biotechnology MUPGRET Workshop.
Food Safety Assessment Kevin Greenlees, PhD, DABT Kathleen Jones, PhD.
Neonatal/Juvenile Animal Safety Studies Kenneth L. Hastings, Dr.P.H., D.A.B.T. Office of New Drugs, CDER.
Regulatory Structure for GE Crops Alan McHughen, D.Phil., University of California Riverside, Ca USA
Jeff Jones, DVM, PhD Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S. Food and Drug Administration Regulation of Genetically.
Good Hygiene Practices along the coffee chain The Codex General Principles of Food Hygiene Module 2.3.
Environmental Safety Assessment Eric Silberhorn, PhD, DABT.
 This training module is relevant to all animal users working with genetically-engineered (GE) farm animals in research, teaching or testing.
Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,
Approaches to Assessing Unintended Health Effects of Genetically Engineered Foods.
Sequencing a genome (a) outline the steps involved in sequencing the genome of an organism; (b) outline how gene sequencing allows for genome-wide comparisons.
Background, Introduction, Statutory Authority, Introduction to Risk-Based Approach Larisa Rudenko, PhD, DABT.
INADs and Beginning the Review Process Larisa Rudenko, PhD, DABT.
Malini M. Wileman, PhD, RAC Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S. Food and Drug Administration Regulation of.
Mrs. Brandi Robinson Office of New Animal Drug Evaluation Center for Veterinary Medicine Regulating Animal Drugs.
Durability Joseph W. (Jay) Cormier, PhD. Describes the animal, construct, and proposed claim Are there sequences that are likely to contain potential.
Product Definition Chapter 4. What is a Medical Device? FDA: “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent,
Codex Guidelines for the Application of HACCP
IPhVWP Polish Presidency, Warsaw October 6 th 2011 Almath Spooner Irish Medicines Board Monitoring the outcome of risk minimisation activities.
Unit 1: The Language of Science  communicate and apply scientific information extracted from various sources (3.B)  evaluate models according to their.
Risk assessment: Bt corn MON810 Risk assessment: identifying and evaluating possible dangers predicting the chances the danger will occur assessing the.
CVM’s Procedure for Setting Tolerances
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science CMC Issues for Screening INDs Eric B. Sheinin, Ph.D. Acting Deputy Director.
Compare and contrast prokaryotic and eukaryotic cells.[BIO.4A] October 2014Secondary Science - Biology.
Dr. Manfred Wentz Director, Hohenstein Institutes (USA) Head, Oeko-Tex Certification Body (USA) AAFA – Environmental Committee Meeting November 10, 2008.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
INTRODUCTION TO TOXICOLOGY SIDNEY GREEN, PH.D. DEPARTMENT OF PHARMACOLOGY COLLEGE OF MEDICINE HOWARD UNIVERISTY.
Biology and You Section 1: Themes of Biology
ERASTUS K. KANG’ETHE UNIVERSITY OF NAIROBI 1 FOOD SAFETY.
Introduction to GMOs: Myths and realities Masami Takeuchi, Ph.D. Food Safety Officer.
CHAPTER 1 VOCABULARY DEFINE THE 26 TERMS IN BOLDFACE IN CHAPTER ONE TEXT. DEFINE THE 26 TERMS IN BOLDFACE IN CHAPTER ONE TEXT. USE THE DEFINITION IN THE.
FEDIAF Guide to Good Practice for the Manufacture of Safe Pet Food TRAINING PACKAGE Module VI Pet food design and formulation Based on Version 9, 2009.
P2-78: Generic Modeling Approach for Quantitative Microbial Risk Assessment Thomas P. Oscar, USDA, ARS/1890 Center of Excellence in Poultry Food Safety.
Codex Science-based Approach to the Safety of Foods Derived from Modern Biotechnology James H. Maryanski, Ph.D. Food and Drug Administration Center for.
COMPARABILITY PROTOCOLUPDATE ADVISORY COMMITTEE FOR PHARMACEUTICAL SCIENCE Manufacturing Subcommittee July 20-21, 2004 Stephen Moore, Ph.D. Chemistry Team.
Public Health and Risk Assessment (2nd of 10 Lectures on Toxicologic Epidemiology) Michael H. Dong MPH, DrPA, PhD  readings.
Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S.
Natalie Brush 3rd Year PhD Student
Generating local intelligence where routine data is not available Simon Packer, Field Epidemiology Service (FES), Public Health England (PHE)
De-anonymizing Genomic Databases Using Phenotypic Traits Humbert et al. Proceedings on Privacy Enhancing Technologies 2015 (2) :
Environmental Assessment of Genetically Engineered Animals at CVM (FDA) Animal Biotechnology Interdisciplinary Group Center for Veterinary Medicine U.S.
Essential Questions What is biology? What are possible benefits of studying biology? What are the characteristics of living things? Introduction to Biology.
European Patients’ Academy on Therapeutic Innovation Special Populations.
GENETICALLY MODIFIED FOOD. Introduction Definition - food or food ingredients that are or are derived from organisms that have been modified through the.
Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern Qualitative Antimicrobial.
1. Consumers, Health, Agriculture and Food Executive Agency Risk assessment with regard to food and feed safety Risk analysis Why risk assessment in the.
© TANUVAS, 2011 Veterinary medical records. Veterinary medical records Introduction  Veterinary medical records meant to provide necessary information.
Genetic Engineering – set of techniques that can be used for the generation of new crop varieties (and other useful organisms). GE is not a farming method.
It’s a food… It’s a drug… It’s AquAdvantage Salmon! Ricardo Carvajal Hyman, Phelps & McNamara, P.C st Annual Tulane.
Susan Makris U.S. EPA, Office of Research and Development
HACCP Essential Tool for Food Safety
9. Introduction to signal detection
The Hazard Analysis Critical Control Point
The Hazard Analysis Critical Control Point
Probiotics and Infant Feeding with B
Regulatory Perspective of the Use of EHRs in RCTs
Nutrition. Good Food Health.
Use Antibiotics Responsibly
Presentation transcript:

Phenotypic Characterization Harlan Howard, PhD

Describes the animal, construct, and proposed claim Are there sequences that are likely to contain potential hazards to the animal, humans, or animals consuming food from that animal, or the environment? e.g., does the construct contain mobilizable sequences from viruses that may be endemic in that species? Does the insertion of the rDNA construct pose a hazard to the animal, humans, other animals by feed, or the environment? What are the direct and indirect risks posed to the GE animal? (e.g., can surveying the health and other phenotypic characteristics of the animal inform us with respect to risk to the animal and potential human food safety concerns?) Phenotypic Characterization What hazards/risks have been identified in the hierarchical review?

Phenotypic Characterization Provides basis for Animal safety evaluation Hazard identification/utility for subsequent steps in process Food safety Environmental safety Durability Claim validation Adjustments to product definition

Animal Health: Direct v Indirect/ Intended v Unintended Effects Direct Adverse Effect (Animal Health) Adverse outcome from rDNA construct insertion Insertional mutagenesis (disruption of coding region) Indirect Adverse Effect (Animal Health) perturbation from Construct (insertion into regulatory region of genome) Gene product perturbing the animal’s physiology Intended effects  Changes resulting from rDNA construct/gene product(s) May or may not pose direct or indirect effects on food safety Unintended effects  Metabolic changes resulting from the interaction of the rDNA construct or its gene product(s) with the physiology of the animal May or may not pose direct or indirect effects on food safety

Hazard to What, Risk to Whom? Humans consume edible products from rDNA animals and possibly experience food consumption risks rDNA construct produces potential hazard(s) in rDNA animals to be used as food

Phenotypic Characterization: Survey of Information-1 May include Health, veterinary, and treatment records Physiology Clinical chemistry Hematology Gross/histological pathology

Phenotypic Characterization -2 Performance (growth, lactation, reproduction) Animal management procedures Nutrition Breeding management Preventative health Determine need for additional studies, depending on unanswered risk questions

Phenotypic Characterization: ATryn Effect of introduction of rDNA construct? Safe for the animal? Does it still function as a goat? Health, Husbandry Data/Information Reviewed Animal breeds, sources, disposition of investigational animals/products Husbandry methods Animal identification, housing, feed, milking, reproduction Health management Physical examinations, preventative procedures, biosecurity measures, routine health observations, necropsy Milk production and composition Production of rhAT in milk

Phenotypic Characterization: ATryn Conclusions Quality housing; biosecure; highly contained General health, growth, milk production, and reproduction of multiple generations the line of goats comparable to non-GE herd-mates/historical comparators Managed similar to non-GE herd-mates; no special management considerations over several generations Milk composition of the line of goats is comparable to non-GE herd-mates or historical comparators (except for the presence of rhAT)